150 related articles for article (PubMed ID: 24687381)
1. Associations of VEGF and VEGFR2 polymorphisms with increased risk and aggressiveness of multiple myeloma.
Brito AB; Lourenço GJ; Oliveira GB; De Souza CA; Vassallo J; Lima CS
Ann Hematol; 2014 Aug; 93(8):1363-9. PubMed ID: 24687381
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of vascular endothelial growth factor and its receptor polymorphisms in endometriosis: a case-control study.
Cardoso JV; Abrão MS; Vianna-Jorge R; Ferrari R; Berardo PT; Machado DE; Perini JA
Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():25-33. PubMed ID: 27836223
[TBL] [Abstract][Full Text] [Related]
3. Association of single nucleotide variants in
Assis-Mendonça GR; Campos LG; Delamain MT; de Brito ABC; Fanelli MF; Soares FA; de Souza CA; Vassallo J; Lima CSP
Leuk Lymphoma; 2023 Dec; 64(13):2165-2177. PubMed ID: 37647140
[TBL] [Abstract][Full Text] [Related]
4. Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans.
Jang MJ; Jeon YJ; Kim JW; Cho YK; Lee SK; Hwang SG; Oh D; Kim NK
Mol Carcinog; 2013 Nov; 52 Suppl 1():E60-9. PubMed ID: 23169005
[TBL] [Abstract][Full Text] [Related]
5. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
[TBL] [Abstract][Full Text] [Related]
6. Associations of
Vasconcelos VCA; Lourenço GJ; Brito ABC; Vasconcelos VL; Maldaun MVC; Tedeschi H; Marie SKN; Shinjo SMO; Lima CSP
Tumour Biol; 2019 Sep; 41(9):1010428319872092. PubMed ID: 31486713
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressiveness.
Sa-Nguanraksa D; Chuangsuwanich T; Pongpruttipan T; Kummalue T; Rojananin S; Ratanawichhitrasin A; Prasarttong-Osoth P; Chuthatisith S; Pisarnturakit P; Aeumrithaicharoenchok W; Rushatamukayanunt P; Lohsiriwat V; Boonsripitayanon M; Malasit P; O-Charoenrat P
Mol Med Rep; 2013 Oct; 8(4):1242-50. PubMed ID: 23904001
[TBL] [Abstract][Full Text] [Related]
8. Association of vascular endothelial growth factor single nucleotide polymorphisms on the prognosis of breast cancer patients.
Rani J; Rahul B; Ramesh G; Krishnamoorthy L; Shilpa C; Ramaswamy G; Deshmane V
Indian J Cancer; 2014; 51(4):512-7. PubMed ID: 26842181
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.
Góra-Tybor J; Szemraj J; Robak T; Jamroziak K
Blood Cells Mol Dis; 2015 Feb; 54(2):139-43. PubMed ID: 25488616
[TBL] [Abstract][Full Text] [Related]
10. Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
Okamoto M; Watanabe M; Inoue N; Ogawa K; Hidaka Y; Iwatani Y
Endocr J; 2020 May; 67(5):545-559. PubMed ID: 32074519
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.
Jang MJ; Kim JW; Jeon YJ; Chong SY; Oh D; Kim NK
Int J Clin Oncol; 2013 Dec; 18(6):1032-41. PubMed ID: 23132736
[TBL] [Abstract][Full Text] [Related]
12. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome.
Lakkireddy S; Aula S; Kapley A; Swamy AV; Digumarti RR; Kutala VK; Jamil K
Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544
[TBL] [Abstract][Full Text] [Related]
13. [Association of single nucleotide polymorphisms in VEGF gene with the risk of endometriosis and adenomyosis].
Liu Q; Li Y; Zhao J; Zhou RM; Wang N; Sun DL; Duan YN; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):165-9. PubMed ID: 19350508
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
Hermann MM; van Asten F; Muether PS; Smailhodzic D; Lichtner P; Hoyng CB; Kirchhof B; Grefkes C; den Hollander AI; Fauser S
Ophthalmology; 2014 Apr; 121(4):905-10. PubMed ID: 24365177
[TBL] [Abstract][Full Text] [Related]
15. Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.
Marotta V; Sciammarella C; Capasso M; Testori A; Pivonello C; Chiofalo MG; Gambardella C; Grasso M; Antonino A; Annunziata A; Macchia PE; Pivonello R; Santini L; Botti G; Losito S; Pezzullo L; Colao A; Faggiano A
J Clin Endocrinol Metab; 2017 Feb; 102(2):661-671. PubMed ID: 27849428
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF) gene polymorphisms and colorectal cancer: a meta-analysis of epidemiologic studies.
Zhao Z; Ba C; Wang W; Wang X; Xue R; Wu X
Genet Test Mol Biomarkers; 2012 Dec; 16(12):1390-4. PubMed ID: 23005896
[TBL] [Abstract][Full Text] [Related]
17. Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms.
Sissung TM; Peer CJ; Korde N; Mailankody S; Kazandjian D; Venzon DJ; Landgren O; Figg WD
Cancer Chemother Pharmacol; 2017 Jul; 80(1):217-221. PubMed ID: 28488026
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A
Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560
[TBL] [Abstract][Full Text] [Related]
19. Role of vascular endothelial growth factor in non‑small cell lung cancer pathogenesis.
Krupnova EV; Shapetska MN; Mikhalenko EP; Chebotaryova NV; Shchayuk AN; Pissarchik SN; Prokhorov AV
Exp Oncol; 2015 Sep; 37(3):213-7. PubMed ID: 26422107
[TBL] [Abstract][Full Text] [Related]
20. FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming.
Bhattacharya R; Ray Chaudhuri S; Roy SS
J Cell Biochem; 2018 Nov; 119(10):8174-8189. PubMed ID: 29904943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
